Physician profile
Patrick J Krach
NPI 1528627973
$283.20
in general payments reported to CMS, 2019-2025
9 companies · $17.37 in 2025
The $17.37 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $48.48 · 2023: $201 · 2024: $16.39 · 2025: $17.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $234.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $53.19 | 2022-2023 | Repatha, Otezla |
| Abbvie INC. | $51.97 | 2023-2025 | |
| Lilly USA, LLC | $46.73 | 2023 | Mounjaro, Jardiance, Emgality |
| Novo Nordisk INC | $31.77 | 2022-2023 | Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $25.00 | 2023 | Arexvy |
| Organogenesis INC. | $24.00 | 2023 | Puraply |
| Teva Pharmaceuticals USA, INC. | $21.18 | 2023 | Austedo |
| Corcept Therapeutics | $16.39 | 2024 | Korlym |
| Astrazeneca Pharmaceuticals Lp | $12.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Krach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.